AI Model Combines EKG and Blood Tests to Assess Heart Transplant Rejection
Researchers at NYU Langone Health said in a press release that an AI model combining electrocardiogram readings with two blood tests could help identify heart transplant rejection without a biopsy in some cases. The study was published online September 25 in the Journal of Heart and Lung Transplantation.
The researchers trained models using 5,300 EKG readings from 2,357 adult heart transplant recipients. One model used EKG data alone, while another combined EKG readings with blood tests that measure gene activity linked to cellular rejection and fragments of donor DNA in a recipient's bloodstream. The team compared model results with biopsy records.
In a separate test group of 38 transplant recipients, the combined model correctly identified 94 percent of patients who were not experiencing rejection. Blood tests alone incorrectly identified 19 patients as potentially needing biopsies. The researchers plan to test the combined model with more patients across several transplant centers.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 6 Vuzix and Shiny Box Develop Military Medical Training for Ultralite Pro Oct 6 Aon review estimates DarioHealth could reduce healthcare costs by 2.5% to 7.2% Oct 6 SAS digital twin earns Fast Company technology recognition Oct 6 Cigna Healthcare Introduces Health Sense for Personalized Care Support Oct 6 Ember AI Launches Partner Program and Oracle Health IntegrationLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
NYU Langone Tests AI Tool to Fill Radiology Training Gaps
Atman Health Wins ARPA-H Award to Build Heart Failure AI
HealthIQ Solutions and Eirion.ai Partner on Predictive AI for Remote Care
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Lunai Bioworks Tests AI Chemical Risk Screening Model
Daily AI Brief: the AI news that matters, in your inbox.